Phase 3 SPECT Clinical Trials
21 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–20 of 21 trials
Recruiting
Phase 2Phase 3
A Phase 2/3 Study on the Efficacy and Safety of Mangaciclanol for Contrast-Enhanced MRI of CNS or Body in Adult Patients
Known or Highly Suspected Central Nervous System (CNS) LesionKnown or Highly Suspected Body (Excluding CNS) Lesion
GE Healthcare640 enrolled1 locationNCT07472491
Recruiting
Phase 3
A Study To Evaluate Pharmacokinetics, Efficacy, Safety, Tolerability, And Pharmacodynamics Of Satralizumab In Pediatric Patients With Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD)
Neuromyelitis Optica Spectrum DisorderNMOSD
Hoffmann-La Roche8 enrolled13 locationsNCT05199688
Recruiting
Phase 3
Choline-PET: Exploratory Study Assessing the Potential Role of F-choline PET Imaging in New and Emerging Indications
Lesion With Known or Suspected F-choline Uptake
Centre hospitalier de l'Université de Montréal (CHUM)500 enrolled1 locationNCT04999215
Recruiting
Phase 2Phase 3
Role of the Gut Vascular Barrier and Microbiota in Autism Spectrum Disorders
AutismAutism Spectrum Disorder (ASD)Autism Disorder
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta90 enrolled2 locationsNCT07450443
Recruiting
Phase 2Phase 3
Targeting the Neurobiology of RRB in Autism Using N-acetylcysteine: Trial
Autism Spectrum Disorder
Stanford University144 enrolled1 locationNCT05664789
Recruiting
Phase 2Phase 3
Efficacy and Safety Study of Ravulizumab IV in Pediatric Participants With NMOSD
Neuromyelitis Optica Spectrum Disorder
Alexion Pharmaceuticals, Inc.12 enrolled21 locationsNCT05346354
Recruiting
Phase 3
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
SchizophreniaAutism Spectrum DisorderBipolar Disorder
Intra-Cellular Therapies, Inc.500 enrolled50 locationsNCT06229210
Recruiting
Phase 3
Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder (ASD) in Pediatric Patients
Irritability Associated With Autism Spectrum Disorder
Intra-Cellular Therapies, Inc.174 enrolled39 locationsNCT06706674
Recruiting
Phase 3
Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatric Patients
Irritability Associated With Autism Spectrum Disorder
Intra-Cellular Therapies, Inc.174 enrolled37 locationsNCT06690398
Recruiting
Phase 3
Early Initiated Ambulance-delivered Levetiracetam and Headposition in Hyper-acute Stroke Trial
Suspected Stroke
Shanghai East Hospital2,423 enrolled2 locationsNCT06773364
Recruiting
Phase 3
JSKN003 Versus Trastuzumab Emtansine (T-DM1) for HER2-Positive, Advanced Breast Cancer
Unrespectable Locally Advanced and or Metastatic HER2 Positive Breast Cancer Participants
Shanghai JMT-Bio Inc.228 enrolled1 locationNCT06846437
Recruiting
Phase 2Phase 3
A Clinical Study of B001 Injection in the Treatment of Neuromyelitis Optica Spectrum Disorders(NMOSD)
Neuromyelitis Optica Spectrum Disorders
Shanghai Jiaolian Drug Research and Development Co., Ltd132 enrolled51 locationsNCT06413654
Not Yet Recruiting
Phase 3
PAPAYA: Pharmacologically-Assisted Psychotherapy for social Anxiety in Young people with Autism
Autism Spectrum DisorderSocial Anxiety Disorder
Orygen156 enrolled1 locationACTRN12624001474549
Recruiting
Phase 2Phase 3
Telehealth-Enabled Versus In-Person Parent-Mediated Behavioral Treatment for Challenging Behaviors in Children With ASD
Autism Spectrum Disorder
Stanford University90 enrolled2 locationsNCT05268796
Active
Phase 2Phase 3
Evaluating the Efficacy of Full-Spectrum Medicinal Cannabis Plant Extract 0.08% THC (NTI164) in Young People with Autism Spectrum Disorder, a Double-Blind, Randomised and Controlled-to-Open-Label Study.
Autism Spectrum Disorder
Fenix Innovation Group54 enrolled1 locationACTRN12622001398796
Not Yet Recruiting
Phase 3
A trial to compare the quality of induction using two different premedication combinations in children with Autism Spectrum Disorder (ASD) undergoing surgery.
Having an operationChildren with Autism Spectrum DisorderNeeding premedication
Murdoch Children Research Institute (MCRI)114 enrolled2 locationsACTRN12616001078448
Recruiting
Phase 3
The SuDDICU Study of Antibiotic Prophylaxis in Critical Illness
Known or suspected infection in critically ill patients in the Intensive Care Unit (ICU)
The George Institute for Global Health15,000 enrolled18 locationsACTRN12615000411549
Completed
Phase 2Phase 3
Permissive HyperthErmiA Through Avoidance of Paracetamol in Known or Suspected Infection in the Intensive Care Unit (ICU)
Known or suspected infection in critically ill patients in the Intensive Care Unit (ICU)
Medical Research Institute of New Zealand700 enrolled1 locationACTRN12612000513819
Active
Phase 2Phase 3
Permissive HyperthErmia Through Avoidance of Paracetamol in Known or Suspected Infection in the Intensive Care Unit (ICU) - pilot study
Known or suspected infection in critically ill patients in ICU
Medical Research Institute of New Zealand30 enrolled1 locationACTRN12611000981921
Completed
Phase 2Phase 3
A course of oxytocin nasal spray (OT) to treat social problems in youth with autism spectrum disorders
Autism Spectrum Disorders
University of Sydney50 enrolled1 locationACTRN12609000513213